James Goding - Opthea Independent Consultant
| CKDXF Stock | USD 0.44 0.00 0.00% |
Insider
James Goding is Independent Consultant of Opthea
| Phone | 61 3 9826 0399 |
| Web | https://opthea.com |
Opthea Management Efficiency
The company has return on total asset (ROA) of (0.6081) % which means that it has lost $0.6081 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.0129) %, meaning that it generated substantial loss on money invested by shareholders. Opthea's management efficiency ratios could be used to measure how well Opthea manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | INSIDER Age | ||
| JeanPaul MD | Inventiva SA | N/A | |
| Michael Cooreman | Inventiva SA | 65 | |
| Eric LLM | Inventiva SA | 49 | |
| Naoya Sato | AnGes Inc | N/A | |
| Ei MD | AnGes Inc | 73 | |
Management Performance
| Return On Equity | -1.01 | |||
| Return On Asset | -0.61 |
Opthea Leadership Team
Elected by the shareholders, the Opthea's board of directors comprises two types of representatives: Opthea inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Opthea. The board's role is to monitor Opthea's management team and ensure that shareholders' interests are well served. Opthea's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Opthea's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, Chief Officer | ||
| MD MBA, Chief Officer | ||
| Michael Gerometta, Manufacturing Chemistry | ||
| Annie Lee, F Mang | ||
| Karen CPA, VP Sec | ||
| Ian Leitch, Director - Clinical Research | ||
| James Goding, Independent Consultant | ||
| MAICD MAICD, CEO MD | ||
| MSc BPHARM, VP Operations |
Opthea Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Opthea a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.01 | |||
| Return On Asset | -0.61 | |||
| Operating Margin | (485.10) % | |||
| Current Valuation | 164.26 M | |||
| Shares Outstanding | 404.98 M | |||
| Shares Owned By Insiders | 8.98 % | |||
| Shares Owned By Institutions | 28.67 % | |||
| Price To Book | 2.75 X | |||
| Price To Sales | 1,669 X | |||
| Revenue | 90.68 K |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Opthea Pink Sheet
Opthea financial ratios help investors to determine whether Opthea Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Opthea with respect to the benefits of owning Opthea security.